IL-33/ST2 axis in innate and acquired immunity to tumors

Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке: https://scidar.kg.ac.rs/handle/123456789/9569

Пун извештај метаподатака

Поље DC-а	Вредност	Језик
dc.rights.license	openAccess	-
dc.contributor.author	Jovanovic I.	-
dc.contributor.author	Pejnović, Nada	-
dc.contributor.author	Radosavljevic, Gordana	-
dc.contributor.author	Arsenijevic, Nebojsa	-
dc.contributor.author	Lukic, Miodrag	-
dc.date.accessioned	2020-09-19T18:36:20Z	-
dc.date.available	2020-09-19T18:36:20Z	-
dc.date.issued	2012	-
dc.identifier.issn	2162-4011	-
dc.identifier.uri	https://scidar.kg.ac.rs/handle/123456789/9569	-
dc.description.abstract	Interleukin-33, a ligand for ST2/T1, has an important role in allergy, autoimmunity and inflammation. The role of IL-33/ST2 axis in cancer is not elucidated. Using metastatic breast cancer model we provide evidence that lack of ST2 signaling led to reduced tumor growth and metastasis and enhanced anti-tumor immunity. © 2012 Landes Bioscience.	-
dc.rights	info:eu-repo/semantics/openAccess	-
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/	-
dc.source	OncoImmunology	-
dc.title	IL-33/ST2 axis in innate and acquired immunity to tumors	-
dc.type	contributionToPeriodical	-
dc.identifier.doi	10.4161/onci.1.2.18131	-
dc.identifier.scopus	2-s2.0-84859924039	-
Налази се у колекцијама:	Faculty of Medical Sciences, Kragujevac

713

18

Датотеке у овој ставци:

Датотека	Опис	Величина	Формат
10.4161-onci.1.2.18131.pdf		536.42 kB	Adobe PDF	Погледајте

SCIDAR - Дигитална архива Универзитета у Крагујевцу